Authors:
TUBIANAMATHIEU N
LEJEUNE C
BONNIER P
GENET D
CLAVERE P
BERDAH JF
DELABY F
ADJADJ D
ROULLET B
MURACCIOLE X
RHEIN B
JUIN P
PIANA L
Citation: N. Tubianamathieu et al., INFLAMMATORY BREAST-CANCER - CHEMOTHERAPY AND CONCOMMITTANT RADIOTHERAPY, European journal of cancer, 34, 1998, pp. 66-66
Authors:
LAGRANGE JL
RAMAIOLI A
CHATEAU MC
PIGNOL JP
MARCHAL C
RESBEUT M
RICHAUD P
RAMBERT P
TORTECHAUX J
SENG SH
DELAFONTAN B
REMESAUMON M
ROULLET B
BOF J
COINDRE JM
Citation: Jl. Lagrange et al., POSTRADIATION SARCOMAS - IMPORTANCE OF SURGERY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 355-355
Authors:
COMTE L
LORGEOT V
VOLKOV L
ROULLET B
TUBIANA N
PRALORAN V
Citation: L. Comte et al., ACSDKP PLASMA-CONCENTRATIONS IN PATIENTS WITH SOLID TUMORS - COMPARISON OF 2 CHEMOTHERAPEUTIC REGIMENS, Cancer letters, 112(1), 1997, pp. 1-4
Authors:
CLAVERE P
BONNETBLANC JM
ROULLET B
ROUSSEAU J
Citation: P. Clavere et al., TREATMENT OF LOCALLY ADVANCED, BASAL-CELL CARCINOMA (BCC) BY NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY, EJD. European journal of dermatology, 6(5), 1996, pp. 383-383
Authors:
KEMP G
ROSE P
LURAIN J
BERMAN M
MANETTA A
ROULLET B
HOMESLEY H
BELPOMME D
GLICK J
Citation: G. Kemp et al., AMIFOSTINE PRETREATMENT FOR PROTECTION AGAINST CYCLOPHOSPHAMIDE-INDUCED AND CISPLATIN-INDUCED TOXICITIES - RESULTS OF A RANDOMIZED CONTROL TRIAL IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 14(7), 1996, pp. 2101-2112
Authors:
FACCHINI T
BELPOMME D
KEMP G
ROSE P
ROULLET B
PHILLIPS P
SCHEFFLER BJ
OSTER W
CAPIZZI RL
SCHEIN PS
Citation: T. Facchini et al., AMIFOSTINE (AMI) SELECTIVELY PROTECTS AGAINST CUMULATIVE TOXICITIES OF CYCLOPHOSPHAMIDE (C) AND CISPLATIN (P), European journal of cancer, 31A, 1995, pp. 500-500
Authors:
SABOT C
DEBORD J
ROULLET B
MARQUET P
MERLE L
LACHATRE G
Citation: C. Sabot et al., COMPARISON OF 2-COMPARTMENT AND 3-COMPARTMENT MODELS FOR THE BAYESIAN-ESTIMATION OF METHOTREXATE PHARMACOKINETICS, International journal of clinical pharmacology and therapeutics, 33(3), 1995, pp. 164-169
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .2. ELEVATED LEVELS OF PLASMA PAF ACETYLHYDROLASE AFTER RAPID INFUSION OF 5-FLUOROURACIL IN CANCER-PATIENTS, Cancer letters, 85(2), 1994, pp. 185-188